کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
2796426 | 1155600 | 2014 | 9 صفحه PDF | دانلود رایگان |
ObjectiveThe most common screening tests for glucose intolerance are fasting plasma glucose (FPG) and glycated hemoglobin (HbA1c). Because it reflects the current status of hyperglycemia, urinary myo-inositol (UMI) may be useful. We evaluated UMI as a screening tool for glucose intolerance.Design and methodsA cross-sectional, community-based population study of 1057 Japanese residents. 173 with an FPG level between 5.5 and 6.9 mmol/L and an HbA1c under 6.5% had an oral glucose tolerance test. We measured UMI level before (fasting UMI) and 2 h after (2 h-UMI) glucose ingestion. Δ-UMI was defined as the difference between fasting UMI and 2 h-UMI.ResultsΔ-UMI, 2 h-UMI and HbA1c levels significantly increased as glucose intolerance worsened. Δ-UMI level was significantly positively correlated with 2 h-UMI level (r = 0.896, p < 0.001). Using cutoff levels from receiver operating characteristic (ROC) analyses, the sensitivity of Δ-UMI (82.1%) and 2 h-UMI (79.3%) were higher than that of HbA1c (48.3%). The area under the ROC curve values for Δ-UMI (0.903) and 2 h-UMI (0.891) were higher than that for HbA1c (0.785).Conclusions2 h-UMI is useful as a non-invasive screening of glucose intolerance.
Journal: Diabetes Research and Clinical Practice - Volume 103, Issue 1, January 2014, Pages 88–96